DDInter211 DDInter1180
A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Biperiden {u} (Compound) resembles {v} (Compound) Oxyphencyclimine
Biperiden {u} (Compound) binds {v} (Gene) CHRNA2
Biperiden {u} (Compound) upregulates {v} (Gene) DFFB
Biperiden {u} (Compound) palliates {v} (Disease) Parkinson's disease
Biperiden {u} (Compound) downregulates {v} (Gene) POLR2I
Biperiden {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Methdilazine
Biperiden {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Tripelennamine
Biperiden {u} may lead to a major life threatening interaction when taken with {v} Potassium chloride
Biperiden (Compound) resembles Oxyphencyclimine (Compound)
Biperiden (Compound) binds CHRNA2 (Gene)
Biperiden (Compound) upregulates DFFB (Gene)
Biperiden (Compound) palliates Parkinson's disease (Disease)
Biperiden (Compound) downregulates POLR2I (Gene)
Biperiden may cause a moderate interaction that could exacerbate diseases when taken with Methdilazine
Biperiden may cause a moderate interaction that could exacerbate diseases when taken with Tripelennamine
Biperiden may lead to a major life threatening interaction when taken with Potassium chloride